Main: +45 31 10 91 91
Fax: +45 77 31 15 09
CVR/VAT no. 31348854
Ordering: +45 29 13 42 24
This is a unique opportunity to join an ambitious and fast-growing company providing solutions for immune monitoring.
Immudex is looking for a CCO who can drive the strategic direction and development of our global sales and marketing teams, strengthening the company's growth and commercial expansion. If you are passionate about strategic sales and commercialization of reagents within the fields of immunology and have a track record in generating sales by developing and executing cutting-edge strategies, you are the person we are looking for.
Immudex is offering an exciting, varied, and challenging job with plenty of opportunities for personal and professional development in an international environment with skilled colleagues and team-oriented working environment. You will be part of Immudex' executive management team.
Your main responsibilities will be to:
As a person you are result driven, committed, and energetic collaborative team player with a proactive and quality-oriented mindset.
You will be situated at our premises in Virum, Denmark, and report directly to the CEO.
Please apply to this position as soon as possible and no later than August 30, 2020. Send your application including CV to email@example.com. For more information about the position, please contact Helene Kähler Hjenner, CEO, at +45 31 10 91 91.
Based in Copenhagen, Denmark, with North American operations based in Fairfax, Virginia, Immudex is a fast-growing life science company providing solutions for immune monitoring within cancer immunotherapy, transplantation, infectious disease, and autoimmunity. With an off-set in Immudex' proprietary Dextramer® and dCODE Dextramer® technologies, the company develops and market research reagents and assay solutions enabling researchers and clinicians to measure disease-specific immunity. All Immudex' products are produced to the highest standards, resulting in reproducible monitoring over time. GMP grade and diagnostic Dextramer reagents are available and currently in use within the USA and Europe. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.